Cargando…

Antibiotic drug discovery

Due to the threat posed by the increase of highly resistant pathogenic bacteria, there is an urgent need for new antibiotics; all the more so since in the last 20 years, the approval for new antibacterial agents had decreased. The field of natural product discovery has undergone a tremendous develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wohlleben, Wolfgang, Mast, Yvonne, Stegmann, Evi, Ziemert, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993170/
https://www.ncbi.nlm.nih.gov/pubmed/27470984
http://dx.doi.org/10.1111/1751-7915.12388
_version_ 1782449118105305088
author Wohlleben, Wolfgang
Mast, Yvonne
Stegmann, Evi
Ziemert, Nadine
author_facet Wohlleben, Wolfgang
Mast, Yvonne
Stegmann, Evi
Ziemert, Nadine
author_sort Wohlleben, Wolfgang
collection PubMed
description Due to the threat posed by the increase of highly resistant pathogenic bacteria, there is an urgent need for new antibiotics; all the more so since in the last 20 years, the approval for new antibacterial agents had decreased. The field of natural product discovery has undergone a tremendous development over the past few years. This has been the consequence of several new and revolutionizing drug discovery and development techniques, which is initiating a ‘New Age of Antibiotic Discovery’. In this review, we concentrate on the most significant discovery approaches during the last and present years and comment on the challenges facing the community in the coming years.
format Online
Article
Text
id pubmed-4993170
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49931702016-08-31 Antibiotic drug discovery Wohlleben, Wolfgang Mast, Yvonne Stegmann, Evi Ziemert, Nadine Microb Biotechnol Special Issue Articles Due to the threat posed by the increase of highly resistant pathogenic bacteria, there is an urgent need for new antibiotics; all the more so since in the last 20 years, the approval for new antibacterial agents had decreased. The field of natural product discovery has undergone a tremendous development over the past few years. This has been the consequence of several new and revolutionizing drug discovery and development techniques, which is initiating a ‘New Age of Antibiotic Discovery’. In this review, we concentrate on the most significant discovery approaches during the last and present years and comment on the challenges facing the community in the coming years. John Wiley and Sons Inc. 2016-07-29 /pmc/articles/PMC4993170/ /pubmed/27470984 http://dx.doi.org/10.1111/1751-7915.12388 Text en © 2016 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Issue Articles
Wohlleben, Wolfgang
Mast, Yvonne
Stegmann, Evi
Ziemert, Nadine
Antibiotic drug discovery
title Antibiotic drug discovery
title_full Antibiotic drug discovery
title_fullStr Antibiotic drug discovery
title_full_unstemmed Antibiotic drug discovery
title_short Antibiotic drug discovery
title_sort antibiotic drug discovery
topic Special Issue Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993170/
https://www.ncbi.nlm.nih.gov/pubmed/27470984
http://dx.doi.org/10.1111/1751-7915.12388
work_keys_str_mv AT wohllebenwolfgang antibioticdrugdiscovery
AT mastyvonne antibioticdrugdiscovery
AT stegmannevi antibioticdrugdiscovery
AT ziemertnadine antibioticdrugdiscovery